In both studies, each patient was treated during 10 separate episodes of breakthrough pain: in seven of these episodes, each patient received Effentora, and in the other three episodes, each patient received placebo (a dummy tablet).
Seitsemässä näistä jaksoista kukin potilas sai Effentoraa ja kolmessa jaksossa kukin potilas sai lumelääketabletin.